+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Osteoporosis Therapeutics - Market Analysis, Trends, and Forecasts

  • ID: 338510
  • Report
  • 158 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Allergan Plc
  • Amgen
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Merck Kgaa
  • MORE
Osteoporosis Therapeutics market worldwide is projected to grow by US$3.7 Billion, driven by a compounded growth of 3.8%. Bisphosphonates, one of the segments analyzed and sized in this study, displays the potential to grow at over 4.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$6.7 Billion by the year 2025, Bisphosphonates will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$133.8 Million to the region's size and clout in the next 5 to 6 years. Over US$107.4 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Bisphosphonates will reach a market size of US$371.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6% over the next couple of years and add approximately US$1 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Allergan PLC
  • Allergan PLC
  • Amgen, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Merck KGaA
  • Novartis International AG
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan Plc
  • Amgen
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Merck Kgaa
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Osteoporosis Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Osteoporosis Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Osteoporosis Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Osteoporosis Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Bisphosphonates (Drug Type) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Bisphosphonates (Drug Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Bisphosphonates (Drug Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Parathyroid Hormone Therapy (Drug Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Parathyroid Hormone Therapy (Drug Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Parathyroid Hormone Therapy (Drug Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Calcitonin (Drug Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Calcitonin (Drug Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Calcitonin (Drug Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Selective Estrogen Inhibitors Modulator (SERM) (Drug Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Selective Estrogen Inhibitors Modulator (SERM) (Drug Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Selective Estrogen Inhibitors Modulator (SERM) (Drug Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Rank Ligand Inhibitors (Drug Type) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 17: Rank Ligand Inhibitors (Drug Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 18: Rank Ligand Inhibitors (Drug Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Osteoporosis Therapeutics Market Share (in %) by Company: 2019 & 2025

TABLE 19: United States Osteoporosis Therapeutics Market Estimates and Projections in US$ Million by Drug Type: 2018 to 2025

TABLE 20: Osteoporosis Therapeutics Market in the United States by Drug Type: A Historic Review in US$ Million for 2009-2017

TABLE 21: United States Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

CANADA

TABLE 22: Canadian Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018 to 2025

TABLE 23: Canadian Osteoporosis Therapeutics Historic Market Review by Drug Type in US$ Million: 2009-2017

TABLE 24: Osteoporosis Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Drug Type for 2009, 2019, and 2025

JAPAN

TABLE 25: Japanese Market for Osteoporosis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Type for the Period 2018-2025

TABLE 26: Osteoporosis Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Drug Type for the Period 2009-2017

TABLE 27: Japanese Osteoporosis Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025

CHINA

TABLE 28: Chinese Osteoporosis Therapeutics Market Growth Prospects in US$ Million by Drug Type for the Period 2018-2025

TABLE 29: Osteoporosis Therapeutics Historic Market Analysis in China in US$ Million by Drug Type: 2009-2017

TABLE 30: Chinese Osteoporosis Therapeutics Market by Drug Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Osteoporosis Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 31: European Osteoporosis Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 32: Osteoporosis Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 33: European Osteoporosis Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 34: European Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018-2025

TABLE 35: Osteoporosis Therapeutics Market in Europe in US$ Million by Drug Type: A Historic Review for the Period 2009-2017

TABLE 36: European Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

FRANCE

TABLE 37: Osteoporosis Therapeutics Market in France by Drug Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 38: French Osteoporosis Therapeutics Historic Market Scenario in US$ Million by Drug Type: 2009-2017

TABLE 39: French Osteoporosis Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025

GERMANY

TABLE 40: Osteoporosis Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025

TABLE 41: German Osteoporosis Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017

TABLE 42: German Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

ITALY

TABLE 43: Italian Osteoporosis Therapeutics Market Growth Prospects in US$ Million by Drug Type for the Period 2018-2025

TABLE 44: Osteoporosis Therapeutics Historic Market Analysis in Italy in US$ Million by Drug Type: 2009-2017

TABLE 45: Italian Osteoporosis Therapeutics Market by Drug Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 46: United Kingdom Market for Osteoporosis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Type for the Period 2018-2025

TABLE 47: Osteoporosis Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Type for the Period 2009-2017

TABLE 48: United Kingdom Osteoporosis Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025

SPAIN

TABLE 49: Spanish Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018 to 2025

TABLE 50: Spanish Osteoporosis Therapeutics Historic Market Review by Drug Type in US$ Million: 2009-2017

TABLE 51: Osteoporosis Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Drug Type for 2009, 2019, and 2025

RUSSIA

TABLE 52: Russian Osteoporosis Therapeutics Market Estimates and Projections in US$ Million by Drug Type: 2018 to 2025

TABLE 53: Osteoporosis Therapeutics Market in Russia by Drug Type: A Historic Review in US$ Million for 2009-2017

TABLE 54: Russian Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 55: Rest of Europe Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018-2025

TABLE 56: Osteoporosis Therapeutics Market in Rest of Europe in US$ Million by Drug Type: A Historic Review for the Period 2009-2017

TABLE 57: Rest of Europe Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 58: Asia-Pacific Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 59: Osteoporosis Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 60: Asia-Pacific Osteoporosis Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 61: Osteoporosis Therapeutics Market in Asia-Pacific by Drug Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 62: Asia-Pacific Osteoporosis Therapeutics Historic Market Scenario in US$ Million by Drug Type: 2009-2017

TABLE 63: Asia-Pacific Osteoporosis Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 64: Osteoporosis Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025

TABLE 65: Australian Osteoporosis Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017

TABLE 66: Australian Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

INDIA

TABLE 67: Indian Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018 to 2025

TABLE 68: Indian Osteoporosis Therapeutics Historic Market Review by Drug Type in US$ Million: 2009-2017

TABLE 69: Osteoporosis Therapeutics Market in India: Percentage Share Breakdown of Sales by Drug Type for 2009, 2019, and 2025

SOUTH KOREA

TABLE 70: Osteoporosis Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025

TABLE 71: South Korean Osteoporosis Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017

TABLE 72: Osteoporosis Therapeutics Market Share Distribution in South Korea by Drug Type: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 73: Rest of Asia-Pacific Market for Osteoporosis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Type for the Period 2018-2025

TABLE 74: Osteoporosis Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Type for the Period 2009-2017

TABLE 75: Rest of Asia-Pacific Osteoporosis Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 76: Latin American Osteoporosis Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 77: Osteoporosis Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 78: Latin American Osteoporosis Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 79: Latin American Osteoporosis Therapeutics Market Growth Prospects in US$ Million by Drug Type for the Period 2018-2025

TABLE 80: Osteoporosis Therapeutics Historic Market Analysis in Latin America in US$ Million by Drug Type: 2009-2017

TABLE 81: Latin American Osteoporosis Therapeutics Market by Drug Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

TABLE 82: Argentinean Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018-2025

TABLE 83: Osteoporosis Therapeutics Market in Argentina in US$ Million by Drug Type: A Historic Review for the Period 2009-2017

TABLE 84: Argentinean Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

BRAZIL

TABLE 85: Osteoporosis Therapeutics Market in Brazil by Drug Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 86: Brazilian Osteoporosis Therapeutics Historic Market Scenario in US$ Million by Drug Type: 2009-2017

TABLE 87: Brazilian Osteoporosis Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025

MEXICO

TABLE 88: Osteoporosis Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025

TABLE 89: Mexican Osteoporosis Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017

TABLE 90: Mexican Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 91: Rest of Latin America Osteoporosis Therapeutics Market Estimates and Projections in US$ Million by Drug Type: 2018 to 2025

TABLE 92: Osteoporosis Therapeutics Market in Rest of Latin America by Drug Type: A Historic Review in US$ Million for 2009-2017

TABLE 93: Rest of Latin America Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 94: The Middle East Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 95: Osteoporosis Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 96: The Middle East Osteoporosis Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 97: The Middle East Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018 to 2025

TABLE 98: The Middle East Osteoporosis Therapeutics Historic Market by Drug Type in US$ Million: 2009-2017

TABLE 99: Osteoporosis Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Drug Type for 2009, 2019, and 2025

IRAN

TABLE 100: Iranian Market for Osteoporosis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Type for the Period 2018-2025

TABLE 101: Osteoporosis Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Drug Type for the Period 2009-2017

TABLE 102: Iranian Osteoporosis Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025

ISRAEL

TABLE 103: Israeli Osteoporosis Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018-2025

TABLE 104: Osteoporosis Therapeutics Market in Israel in US$ Million by Drug Type: A Historic Review for the Period 2009-2017

TABLE 105: Israeli Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 106: Saudi Arabian Osteoporosis Therapeutics Market Growth Prospects in US$ Million by Drug Type for the Period 2018-2025

TABLE 107: Osteoporosis Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Drug Type: 2009-2017

TABLE 108: Saudi Arabian Osteoporosis Therapeutics Market by Drug Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

TABLE 109: Osteoporosis Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025

TABLE 110: United Arab Emirates Osteoporosis Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017

TABLE 111: Osteoporosis Therapeutics Market Share Distribution in United Arab Emirates by Drug Type: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 112: Osteoporosis Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025

TABLE 113: Rest of Middle East Osteoporosis Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017

TABLE 114: Rest of Middle East Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

AFRICA

TABLE 115: African Osteoporosis Therapeutics Market Estimates and Projections in US$ Million by Drug Type: 2018 to 2025

TABLE 116: Osteoporosis Therapeutics Market in Africa by Drug Type: A Historic Review in US$ Million for 2009-2017

TABLE 117: African Osteoporosis Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

IV. COMPETITION

ALLERGAN PLC

AMGEN

ELI LILLY AND COMPANY

F. HOFFMANN-LA ROCHE AG

GLAXOSMITHKLINE PLC

MERCK KGAA

NOVARTIS INTERNATIONAL AG

NOVO NORDISK A/S

PFIZER

TEVA PHARMACEUTICAL INDUSTRIES

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan Plc
  • Amgen
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Merck Kgaa
  • Novartis International Ag
  • Novo Nordisk A/S
  • Pfizer
  • Teva Pharmaceutical Industries
Note: Product cover images may vary from those shown
Adroll
adroll